In 2023, the pharmaceutical imports in Australia stood at 13.60 billion USD. Forecasted data shows a consistent upward trend in the coming years. In 2024, imports are expected to rise by 8.24% reaching 14.72 billion USD. They continue to grow by 7.89% in 2025, 7.25% in 2026, 6.70% in 2027, and 6.21% in 2028. The compound annual growth rate (CAGR) over the five-year forecast period is approximately 7.26%.
Future trends to watch for include:
- Innovation in pharmaceutical technology driving import demands.
- Regulatory changes in Australia influencing import dynamics.
- Global supply chain disruptions and their impacts.
- Increasing healthcare investment and aging population fueling import growth.
